US will make millions of bird flu vaccines this summer
Jun 03, 2024
As the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million doses of flu vaccine are now being prepared for possible use in humans.
‘Viral fusion’ fuels extra-potent vaccine for RSV, could be deployed for flu, researchers say
By
Aaron Dorman
Mar 19, 2024
A new “3D vaxlock” process creates a vaccine 11 times more potent than “standard industry comparators,” new research shows.
Upcoming study will ‘Detect & Protect’ seniors against viral infections like flu, COVID
By
Aaron Dorman
Nov 01, 2023
A new study program, Detect & Protect, will use AI models that can pull from wearables data and better predict viral infections.
In early trial, results promising for Moderna combo COVID-flu vaccine
Oct 05, 2023
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025.
Big senior living stories of 2022
By
Lois A. Bowers
Dec 22, 2022
Here are some of the major stories that affected senior living providers in 2022.
LTC Properties ‘not sitting here waiting’ for Brookdale’s next move, CEO says
By
Lois A. Bowers
Oct 31, 2022
With Brookdale Senior Living’s lease with real estate investment trust LTC Properties up in 2023 and rumors swirling that the Brentwood, TN-based senior living operator is shopping for a buyer, the Westlake...
Flu vaccine offers moderate protection from stroke
Sep 07, 2022
After full adjustment, an association between influenza vaccination and ischemic stroke yielded an adjusted odds ratio of 0.88.
CDC recommendations for influenza vaccination updated for 2021-2022
Aug 31, 2021
When more than one licensed, recommended, age-appropriate vaccine is available, ACIP makes no preferential recommendations.
Big senior living stories of 2019
By
Lois A. Bowers
Dec 23, 2019
Here’s a look at some of the news that occupied many minds in senior living over the past year.
FDA approves new flu vaccine option for older adults
By
Lois A. Bowers
Nov 06, 2019
The Food and Drug Administration has approved a new influenza vaccine for people aged 65 or more years, biopharmaceutical company Sanofi announced Monday.